Biopharma / Medtech Reports

May 15, 2025

NIH & Lab Tools: Law vs Politics

•

John Leppard

AVTR (US), BRKR (US), DHR (US), ILMN (US), RVTY (US), TMO (US)
May 12, 2025

Rx Pricing’s Lucy & the Football Moment?

•

John Leppard

AMGN (US), BMY (US), GSK (US), LLY (US), MRK (US), NVO (US), REGN (US), UTHR (US)
May 7, 2025

Rx MFN Announcement Monday?

•

John Leppard
May 7, 2025

Rx Most Favored Nation (MFN) Estimates

•

John Leppard

ABBV (US), AMGN (US), GILD (US)
May 1, 2025

GKOS: iDose & iStent Policy Landscape

•

John Leppard

GKOS (US)
April 29, 2025

[EXAS] Screening Uncertainty Post-SCOTUS?

•

John Leppard

EXAS (US), GH (US)
April 21, 2025

Diagnostics: Supreme Court Quick Takes

•

John Leppard

EXAS (US), GH (US), HOLX (US), MYGN (US), NEO (US)
April 21, 2025

Diagnostics & Supreme Court Expectations

•

John Leppard

EXAS (US), GH (US), HOLX (US), MYGN (US), NEO (US), OSUR (US)
April 17, 2025

Rx Executive Order: Style of Substance

•

John Leppard
April 17, 2025

Life Science Tools: NIH Headwinds & Congressional Guardrails

•

John Leppard

A (US), AVTR (US), BRKR (US), ILMN (US), MTD (US), TMO (US)